Register now: European Biotech Partnering @EBDC 2018 – Bridging Medical Information
The European Business Development Conference (EBDC) is a perfect platform to liaise with Central Europe’s biotech industry. Organized by Germany’s biotech industry association BIO Deutschland in cooperation with a dozen European regional clusters and national associations EBDC is a successful and well established networking event for decision makers from Biotech, Pharma and the Investment sector.
We look forward to opening keynotes form Evotec CEO Werner Lanthaler and Niels Emmerich, VP Global Head Search and Evaluation at Abbvie. Our main topics will be Gene & Cell therapy, Brexit and its impact on Biotech, Big Data in drug development and Before and After the IPO (in collaboration with Euronext). Confirmed speakers in these symposia include representatives of Abivax, Cellmedica, Flatiron, GeNeuro, Life Science Partners, Miltenyi Biotec, Molecular Health, Novartis and QIAGEN. We will also hear about unmet medical needs with spotlight talks on cardiovascular from AstraZeneca, on CNS from Boehringer Ingelheim and on orphan diseases from Sanofi.
Life Science industry success is all about having the right partners. EBDC puts company presentations on the main stage with no competing program or partnering. We would like to encourage you to apply for such a company presentation.
Gain the attention of high class attendees at a conference with a more familiar atmosphere than at common partnering events and apply for a company presentation by registering online to the EBDC (1,095 EUR for members of BIO Deutschland or of one of our international partners, 1,975 EUR for non-members). Or register for regular attendance without presentation (545 EUR for members of BIO Deutschland or of one of our international partners, 985 EUR for non-members): www.biodeutschland.org/de/european-business-development-conference-2018.html